dmards
- 网络改善病情抗风湿药;抗风湿药;缓解病情抗风湿药;抗风湿药物;改善病情的抗风湿药
-
Comparison of Efficacy and Safety of Different DMARDs Combination Therapies for Rheumatoid Arthritis
改善病情抗风湿药联合治疗类风湿性关节炎的疗效及安全性比较
-
Conclusion : There were disease modifying anti rheumatic drugs ( DMARDs ) in the treatment of RA with MTX .
提示:MTX治疗RA有缓解病情抗风湿药(DMARDs)作用。
-
Therefore , substantial revenue opportunity for conventional disease-modifying antirheumatic drugs ( DMARDs ) remains in early lines of therapy .
因此,在早期治疗中,常规抗风湿性关节炎疾病缓解用药还有很大市场。
-
Currently , Western medicine treatment of RA is mainly to non-steroidal anti-inflammatory drugs ( NSAIDS ) and remission of disease anti-rheumatic drugs ( DMARDs ) based .
目前,西医治疗RA主要以非甾体类抗炎药(NSAIDS)和缓解病情抗风湿药物(DMARDS)为主。
-
Therapeutic agents , such as disease modifying anti-rheumatic drugs ( DMARDs ), non-steroidal anti-inflammatory drugs ( NSAIDs ) and hormone drugs are clinically common .
临床常见的药物有:缓解类风湿性关节炎的药物,非甾体抗炎药,激素类药物。
-
In recent years , biologic disease-modifying anti-rheumatic drugs ( DMARDs ) have been introduced that can help to modify this irregular immune response and improve symptoms of the disease .
近年来已生产出缓解疾病的抗风湿性生物制剂(DMARDs),这能有助于改善不规则的免疫应答、改善这种疾病的症状。